STOCK TITAN

CBD LIFE SCIENCES INC - CBDL STOCK NEWS

Welcome to our dedicated page for CBD LIFE SCIENCES news (Ticker: CBDL), a resource for investors and traders seeking the latest updates and insights on CBD LIFE SCIENCES stock.

CBD Life Sciences Inc. (CBDL) is a company focused on identifying, evaluating, and exploiting opportunities in the CBD space. Led by CEO Lisa Nelson, the company recently underwent a reverse split to rebrand its CBD products and launch a new product website. The rebranding is near completion, with an expected launch in mid-May 2024. CBDL aims to drive sales growth through wholesale and retail channel partnerships, with a full line of hemp-based organic products including CBD drops, pain relief creams, anxiety and sleep supplements, gummies, cartridges, and a pet line.

Rhea-AI Summary

CBD Life Sciences (CBDL) is applying for an Agricultural Hemp License in Arizona through its subsidiary LBC Bioscience Inc.. This license will enable the company to establish a grow facility and explore diverse product offerings including flower, edibles, oils, and creams. President & CEO Lisa Nelson emphasized the potential for significant revenue growth, citing the versatility of hemp with over 25,000 uses. The global CBD market is projected to reach USD 13.4 billion by 2028 with a 21.2% CAGR. Additionally, CBD Life Sciences is nearing the opening of its third retail location.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.33%
Tags
none
-
Rhea-AI Summary

SCOTTSDALE, AZ / ACCESSWIRE / August 18, 2021 / CBD Life Sciences (OTC PINK:CBDL) will participate in the White Label Expo in Las Vegas on September 1-2, showcasing its products to a projected audience of 15,000 attendees. The expo will feature 300 exhibitors and 200 seminars, focusing on innovations in white label goods. Lisa Nelson, President & CEO, expressed excitement for the opportunity to expand product reach. Additionally, CBD Life Sciences is nearing its third retail location, indicating significant growth potential. The company plans to keep its stakeholders informed on developments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) expands its product line with new Vegan, non-GMO Gluten Free Gummies, boasting 20mg of hemp extract per 4oz jar in flavors like candy apple and blue raspberry. CEO Lisa Nelson highlights a commitment to high-quality ingredients, catering to a wider demographic including vegans and those with dietary restrictions. The gummies aim to manage stress and enhance sleep. Soon available online and on Amazon, this launch coincides with the company's plans for a third retail location, indicating further revenue growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) has announced the launch of new Delta-10 Cartridges through its subsidiary, LBC Bioscience Inc. Available in Sour Diesel and Blue Dream strains, each cartridge contains 900MG of Delta-10-THC. This cannabinoid is federally legal and is gaining popularity due to its uplifting effects without the paranoia associated with Delta-9-THC. Additionally, CBD Life Sciences is expanding its retail presence, nearing its third retail location and a recreational marijuana facility, contributing to potential revenue growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (CBDL) has announced the launch of its new 3000MG Pain Relief Cream, significantly stronger than its previous 1200MG version. President & CEO Lisa Nelson emphasizes the cream's effectiveness for athletes and professionals, promising immediate relief without psychotropic effects. The product targets customers like athletes and healthcare professionals, offering localized pain relief. The company is also nearing its third retail location, hinting at future revenue growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK: CBDL) has successfully opened its second retail location, The CBD Vault, on June 12, 2021, in Scottsdale, AZ. The grand opening attracted over 200 customers, with all four new strains of Delta-8 cartridges selling out within the first hour. The company plans further expansion, with third and fourth locations in Sedona and Las Vegas, and is exploring a recreational marijuana facility. This expansion is expected to drive revenue growth as CBD Life Sciences continues to enhance its product offerings and retail presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) has appointed Matthew McGee as its new Chief Marketing Officer, effective immediately. McGee brings experience in the cannabis sector and a strong background in customer marketing strategies. He aims to enhance the company's growth and expand its sales. President & CEO Lisa Nelson expressed confidence in McGee's leadership capabilities. LBC Bioscience, a subsidiary of CBD Life Sciences, is already well-stocked with high-quality CBD products, including oils and wellness items, and is poised for further market expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.64%
Tags
management
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) announces its second retail store grand opening on June 12 in Scottsdale, AZ. CEO Lisa Nelson highlights the company’s ongoing expansion, including plans for a third location in Sedona and potential fourth on the Las Vegas Strip. The firm is capitalizing on Arizona's new recreational cannabis market, allowing it to offer premium products to a wider audience. Following recent approval for Amazon sales, CBD Life Sciences is optimistic about growth and revenue for the remainder of 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) announces the launch of two popular products on its Amazon Store: 1200MG Pain Relief Cream and CBD gummy bears (150MG and 350MG). CEO Lisa Nelson highlights the significance of entering the Amazon marketplace as a key step for the company's growth in the expanding hemp market. The company reports strong initial revenue from these products and plans to expand its offerings further. Additionally, CBD Life Sciences Inc. is exploring opportunities in Arizona's recreational cannabis market, positioning itself for future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
none
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) announced the grand opening of its Amazon store, showcasing its hemp-based products, including the new Green Tea Facial Cleanser. CEO Lisa Nelson emphasized the significance of this partnership in reaching new customers and enhancing product visibility. The company is planning to expand its product range on Amazon, which includes items like Pain Relief Roll-On and Pain Cream. Additionally, CBD Life Sciences is pursuing opportunities in Arizona's recreational cannabis market, enabling the sale of premium cannabis products to a broader customer base.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
none

FAQ

What is the current stock price of CBD LIFE SCIENCES (CBDL)?

The current stock price of CBD LIFE SCIENCES (CBDL) is $0.0004 as of December 20, 2024.

What is the market cap of CBD LIFE SCIENCES (CBDL)?

The market cap of CBD LIFE SCIENCES (CBDL) is approximately 1.4M.

What is CBD Life Sciences Inc. focused on?

CBD Life Sciences Inc. is focused on identifying, evaluating, and exploiting opportunities in the CBD space.

Who is the CEO of CBD Life Sciences Inc.?

The CEO of CBD Life Sciences Inc. is Lisa Nelson.

What recent change did CBD Life Sciences Inc. undergo?

CBD Life Sciences Inc. recently underwent a reverse split to rebrand its CBD products and launch a new product website.

When is the expected launch of the rebranded products?

The expected launch of the rebranded products is in mid-May 2024.

What products does CBD Life Sciences Inc. offer?

CBD Life Sciences Inc. offers a full line of hemp-based organic products, including CBD drops, pain relief creams, anxiety and sleep supplements, gummies, cartridges, and a pet line.

How does CBD Life Sciences Inc. plan to drive sales growth?

CBD Life Sciences Inc. plans to drive sales growth through wholesale and retail channel partnerships.

Where can shareholders and investors follow CBD Life Sciences Inc. for news and updates?

Shareholders, investors, and business partners can follow CBD Life Sciences Inc. on X: @cbdlifescience for news and updates.

What is the Safe Harbor Statement of CBD Life Sciences Inc.?

The Safe Harbor Statement of CBD Life Sciences Inc. states that forward-looking statements are based on current beliefs, expectations, and assumptions regarding the future.

How does CBD Life Sciences Inc. approach its ultimate objective of increasing shareholder value?

CBD Life Sciences Inc. approaches its ultimate objective of increasing shareholder value by seeking additional opportunities within the CBD sector.

Where can interested parties find more information about CBD Life Sciences Inc.?

Interested parties can find more information about CBD Life Sciences Inc. in its filings with the Securities and Exchange Commission and quarterly disclosure report on the OTC Markets.

CBD LIFE SCIENCES INC

OTC:CBDL

CBDL Rankings

CBDL Stock Data

1.39M
141.69M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Scottsdale